カテゴリー： QYResearch, 世界

世界の急性心不全(AHF)治療薬市場 2019年

【英語タイトル】Global Acute Heart Failure (AHF) Therapeutics Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X02947）・商品コード：DATA909X02947
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、急性心不全(AHF)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、β遮断薬、カルシウム拮抗薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他に、用途別には、病院、クリニック、ホームケアにセグメント区分し、急性心不全(AHF)治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・急性心不全(AHF)治療薬の世界市場概要
・急性心不全(AHF)治療薬の製造コスト構成分析
・急性心不全(AHF)治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・急性心不全(AHF)治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・急性心不全(AHF)治療薬のセグメント分析（種類別）
（β遮断薬、カルシウム拮抗薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他）
・急性心不全(AHF)治療薬のセグメント分析（用途別）
（病院、クリニック、ホームケア）
・急性心不全(AHF)治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Bayer AG、Bristol-Myers Squibb Company、Cardiorentis AG、CVie Therapeutics Limited、Cytokinetics, Inc.、Merck & Co.、Novartis AG、Orion Corporation、PhaseBio Pharmaceuticals, Inc、）
・急性心不全(AHF)治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Acute Heart Failure (AHF) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Acute Heart Failure (AHF) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Heart Failure (AHF) Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Acute Heart Failure (AHF) Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Acute Heart Failure (AHF) Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bayer AG
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Cytokinetics, Inc.
Merck & Co.
Novartis AG
Orion Corporation
PhaseBio Pharmaceuticals, Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Others

Segment by Application
Hospital
Clinic
Home Care

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Acute Heart Failure (AHF) Therapeutics
1.1 Definition of Acute Heart Failure (AHF) Therapeutics
1.2 Acute Heart Failure (AHF) Therapeutics Segment by Type
1.2.1 Global Acute Heart Failure (AHF) Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 B-Blockers
1.2.3 Calcium Channel Blockers
1.2.4 Cardiac Glycosides
1.2.5 Diuretics
1.2.6 Morphine
1.2.7 Vasodilators/Nitrates
1.2.8 Others
1.3 Acute Heart Failure (AHF) Therapeutics Segment by Applications
1.3.1 Global Acute Heart Failure (AHF) Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Global Acute Heart Failure (AHF) Therapeutics Overall Market
1.4.1 Global Acute Heart Failure (AHF) Therapeutics Revenue (2014-2025)
1.4.2 Global Acute Heart Failure (AHF) Therapeutics Production (2014-2025)
1.4.3 North America Acute Heart Failure (AHF) Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Acute Heart Failure (AHF) Therapeutics Status and Prospect (2014-2025)
1.4.5 China Acute Heart Failure (AHF) Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Acute Heart Failure (AHF) Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Acute Heart Failure (AHF) Therapeutics Status and Prospect (2014-2025)
1.4.8 India Acute Heart Failure (AHF) Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Acute Heart Failure (AHF) Therapeutics
2.3 Manufacturing Process Analysis of Acute Heart Failure (AHF) Therapeutics
2.4 Industry Chain Structure of Acute Heart Failure (AHF) Therapeutics

3 Development and Manufacturing Plants Analysis of Acute Heart Failure (AHF) Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Acute Heart Failure (AHF) Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Acute Heart Failure (AHF) Therapeutics
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Acute Heart Failure (AHF) Therapeutics Production and Capacity Analysis
4.2 Acute Heart Failure (AHF) Therapeutics Revenue Analysis
4.3 Acute Heart Failure (AHF) Therapeutics Price Analysis
4.4 Market Concentration Degree

5 Acute Heart Failure (AHF) Therapeutics Regional Market Analysis
5.1 Acute Heart Failure (AHF) Therapeutics Production by Regions
5.1.1 Global Acute Heart Failure (AHF) Therapeutics Production by Regions
5.1.2 Global Acute Heart Failure (AHF) Therapeutics Revenue by Regions
5.2 Acute Heart Failure (AHF) Therapeutics Consumption by Regions
5.3 North America Acute Heart Failure (AHF) Therapeutics Market Analysis
5.3.1 North America Acute Heart Failure (AHF) Therapeutics Production
5.3.2 North America Acute Heart Failure (AHF) Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Acute Heart Failure (AHF) Therapeutics Import and Export
5.4 Europe Acute Heart Failure (AHF) Therapeutics Market Analysis
5.4.1 Europe Acute Heart Failure (AHF) Therapeutics Production
5.4.2 Europe Acute Heart Failure (AHF) Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Acute Heart Failure (AHF) Therapeutics Import and Export
5.5 China Acute Heart Failure (AHF) Therapeutics Market Analysis
5.5.1 China Acute Heart Failure (AHF) Therapeutics Production
5.5.2 China Acute Heart Failure (AHF) Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Acute Heart Failure (AHF) Therapeutics Import and Export
5.6 Japan Acute Heart Failure (AHF) Therapeutics Market Analysis
5.6.1 Japan Acute Heart Failure (AHF) Therapeutics Production
5.6.2 Japan Acute Heart Failure (AHF) Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Acute Heart Failure (AHF) Therapeutics Import and Export
5.7 Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Analysis
5.7.1 Southeast Asia Acute Heart Failure (AHF) Therapeutics Production
5.7.2 Southeast Asia Acute Heart Failure (AHF) Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Acute Heart Failure (AHF) Therapeutics Import and Export
5.8 India Acute Heart Failure (AHF) Therapeutics Market Analysis
5.8.1 India Acute Heart Failure (AHF) Therapeutics Production
5.8.2 India Acute Heart Failure (AHF) Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Acute Heart Failure (AHF) Therapeutics Import and Export

6 Acute Heart Failure (AHF) Therapeutics Segment Market Analysis (by Type)
6.1 Global Acute Heart Failure (AHF) Therapeutics Production by Type
6.2 Global Acute Heart Failure (AHF) Therapeutics Revenue by Type
6.3 Acute Heart Failure (AHF) Therapeutics Price by Type

7 Acute Heart Failure (AHF) Therapeutics Segment Market Analysis (by Application)
7.1 Global Acute Heart Failure (AHF) Therapeutics Consumption by Application
7.2 Global Acute Heart Failure (AHF) Therapeutics Consumption Market Share by Application (2014-2019)

8 Acute Heart Failure (AHF) Therapeutics Major Manufacturers Analysis
8.1 Bayer AG
8.1.1 Bayer AG Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
8.1.2 Bayer AG Product Introduction, Application and Specification
8.1.3 Bayer AG Acute Heart Failure (AHF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bristol-Myers Squibb Company
8.2.1 Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
8.2.3 Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Cardiorentis AG
8.3.1 Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
8.3.2 Cardiorentis AG Product Introduction, Application and Specification
8.3.3 Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 CVie Therapeutics Limited
8.4.1 CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
8.4.2 CVie Therapeutics Limited Product Introduction, Application and Specification
8.4.3 CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Cytokinetics, Inc.
8.5.1 Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
8.5.2 Cytokinetics, Inc. Product Introduction, Application and Specification
8.5.3 Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Merck & Co.
8.6.1 Merck & Co. Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
8.6.2 Merck & Co. Product Introduction, Application and Specification
8.6.3 Merck & Co. Acute Heart Failure (AHF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Novartis AG
8.7.1 Novartis AG Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
8.7.2 Novartis AG Product Introduction, Application and Specification
8.7.3 Novartis AG Acute Heart Failure (AHF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Orion Corporation
8.8.1 Orion Corporation Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
8.8.2 Orion Corporation Product Introduction, Application and Specification
8.8.3 Orion Corporation Acute Heart Failure (AHF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 PhaseBio Pharmaceuticals, Inc
8.9.1 PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
8.9.2 PhaseBio Pharmaceuticals, Inc Product Introduction, Application and Specification
8.9.3 PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Acute Heart Failure (AHF) Therapeutics Market
9.1 Global Acute Heart Failure (AHF) Therapeutics Market Trend Analysis
9.1.1 Global Acute Heart Failure (AHF) Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Acute Heart Failure (AHF) Therapeutics Regional Market Trend
9.2.1 North America Acute Heart Failure (AHF) Therapeutics Forecast 2019-2025
9.2.2 Europe Acute Heart Failure (AHF) Therapeutics Forecast 2019-2025
9.2.3 China Acute Heart Failure (AHF) Therapeutics Forecast 2019-2025
9.2.4 Japan Acute Heart Failure (AHF) Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Acute Heart Failure (AHF) Therapeutics Forecast 2019-2025
9.2.6 India Acute Heart Failure (AHF) Therapeutics Forecast 2019-2025
9.3 Acute Heart Failure (AHF) Therapeutics Market Trend (Product Type)
9.4 Acute Heart Failure (AHF) Therapeutics Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Acute Heart Failure (AHF) Therapeutics Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Acute Heart Failure (AHF) Therapeutics
Table Global Acute Heart Failure (AHF) Therapeutics Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Acute Heart Failure (AHF) Therapeutics Production Market Share by Types in 2018
Figure B-Blockers Product Picture
Figure Calcium Channel Blockers Product Picture
Figure Cardiac Glycosides Product Picture
Figure Diuretics Product Picture
Figure Morphine Product Picture
Figure Vasodilators/Nitrates Product Picture
Figure Others Product Picture
Table Global Acute Heart Failure (AHF) Therapeutics Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Acute Heart Failure (AHF) Therapeutics Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Home Care
Figure Global Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Acute Heart Failure (AHF) Therapeutics Production (K Pcs) (2014-2025)
Figure North America Acute Heart Failure (AHF) Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Acute Heart Failure (AHF) Therapeutics Market Size (Million USD) (2014-2025)
Figure China Acute Heart Failure (AHF) Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Acute Heart Failure (AHF) Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size (Million USD) (2014-2025)
Figure India Acute Heart Failure (AHF) Therapeutics Market Size (Million USD) (2014-2025)
Table Acute Heart Failure (AHF) Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Acute Heart Failure (AHF) Therapeutics in 2018
Figure Manufacturing Process Analysis of Acute Heart Failure (AHF) Therapeutics
Figure Industry Chain Structure of Acute Heart Failure (AHF) Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Acute Heart Failure (AHF) Therapeutics Manufacturing Plants Distribution
Table Acute Heart Failure (AHF) Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Acute Heart Failure (AHF) Therapeutics Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Acute Heart Failure (AHF) Therapeutics Production (K Pcs) of Major Manufacturers (2014-2019)
Table Acute Heart Failure (AHF) Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Acute Heart Failure (AHF) Therapeutics Production Share by Manufacturers in 2018
Table Acute Heart Failure (AHF) Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Acute Heart Failure (AHF) Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Acute Heart Failure (AHF) Therapeutics Revenue Share by Manufacturers in 2018
Table Acute Heart Failure (AHF) Therapeutics Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Acute Heart Failure (AHF) Therapeutics Production by Regions 2014-2019 (K Pcs)
Table Global Acute Heart Failure (AHF) Therapeutics Production Market Share by Regions 2014-2019
Figure Global Acute Heart Failure (AHF) Therapeutics Production Market Share by Regions in 2018
Table Global Acute Heart Failure (AHF) Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Regions in 2018
Table Global Acute Heart Failure (AHF) Therapeutics Consumption by Regions 2014-2019 (K Pcs)
Table Global Acute Heart Failure (AHF) Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Acute Heart Failure (AHF) Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure North America Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Acute Heart Failure (AHF) Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Europe Acute Heart Failure (AHF) Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Acute Heart Failure (AHF) Therapeutics Production, Consumption Import and Export (K Pcs)
Figure China Acute Heart Failure (AHF) Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure China Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Acute Heart Failure (AHF) Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Japan Acute Heart Failure (AHF) Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Acute Heart Failure (AHF) Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Acute Heart Failure (AHF) Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Acute Heart Failure (AHF) Therapeutics Production, Consumption Import and Export (K Pcs)
Figure India Acute Heart Failure (AHF) Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure India Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Acute Heart Failure (AHF) Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Acute Heart Failure (AHF) Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Acute Heart Failure (AHF) Therapeutics Market Share by Application (2014-2019)
Table Bayer AG Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
Table Bayer AG Acute Heart Failure (AHF) Therapeutics Product Introduction, Application and Specification
Table Bayer AG Acute Heart Failure (AHF) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG Acute Heart Failure (AHF) Therapeutics Production Growth Rate (2014-2019)
Table Bayer AG Acute Heart Failure (AHF) Therapeutics Production Market Share (2014-2019)
Figure Bayer AG Acute Heart Failure (AHF) Therapeutics Revenue Market Share (2014-2019)
Table Bayer AG Acute Heart Failure (AHF) Therapeutics Main Business and Markets Served
Table Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
Table Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Product Introduction, Application and Specification
Table Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Main Business and Markets Served
Table Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
Table Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Product Introduction, Application and Specification
Table Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Production Growth Rate (2014-2019)
Table Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Production Market Share (2014-2019)
Figure Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Revenue Market Share (2014-2019)
Table Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Main Business and Markets Served
Table CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
Table CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Product Introduction, Application and Specification
Table CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Production Growth Rate (2014-2019)
Table CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Production Market Share (2014-2019)
Figure CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Revenue Market Share (2014-2019)
Table CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Main Business and Markets Served
Table Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
Table Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Product Introduction, Application and Specification
Table Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Production Growth Rate (2014-2019)
Table Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Production Market Share (2014-2019)
Figure Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Revenue Market Share (2014-2019)
Table Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Main Business and Markets Served
Table Merck & Co. Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
Table Merck & Co. Acute Heart Failure (AHF) Therapeutics Product Introduction, Application and Specification
Table Merck & Co. Acute Heart Failure (AHF) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co. Acute Heart Failure (AHF) Therapeutics Production Growth Rate (2014-2019)
Table Merck & Co. Acute Heart Failure (AHF) Therapeutics Production Market Share (2014-2019)
Figure Merck & Co. Acute Heart Failure (AHF) Therapeutics Revenue Market Share (2014-2019)
Table Merck & Co. Acute Heart Failure (AHF) Therapeutics Main Business and Markets Served
Table Novartis AG Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
Table Novartis AG Acute Heart Failure (AHF) Therapeutics Product Introduction, Application and Specification
Table Novartis AG Acute Heart Failure (AHF) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Acute Heart Failure (AHF) Therapeutics Production Growth Rate (2014-2019)
Table Novartis AG Acute Heart Failure (AHF) Therapeutics Production Market Share (2014-2019)
Figure Novartis AG Acute Heart Failure (AHF) Therapeutics Revenue Market Share (2014-2019)
Table Novartis AG Acute Heart Failure (AHF) Therapeutics Main Business and Markets Served
Table Orion Corporation Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
Table Orion Corporation Acute Heart Failure (AHF) Therapeutics Product Introduction, Application and Specification
Table Orion Corporation Acute Heart Failure (AHF) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Orion Corporation Acute Heart Failure (AHF) Therapeutics Production Growth Rate (2014-2019)
Table Orion Corporation Acute Heart Failure (AHF) Therapeutics Production Market Share (2014-2019)
Figure Orion Corporation Acute Heart Failure (AHF) Therapeutics Revenue Market Share (2014-2019)
Table Orion Corporation Acute Heart Failure (AHF) Therapeutics Main Business and Markets Served
Table PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Production Sites and Area Served
Table PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Product Introduction, Application and Specification
Table PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Production Growth Rate (2014-2019)
Table PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Production Market Share (2014-2019)
Figure PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Revenue Market Share (2014-2019)
Table PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Main Business and Markets Served
Figure Global Acute Heart Failure (AHF) Therapeutics Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Acute Heart Failure (AHF) Therapeutics Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Acute Heart Failure (AHF) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Acute Heart Failure (AHF) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Acute Heart Failure (AHF) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Acute Heart Failure (AHF) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Acute Heart Failure (AHF) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Acute Heart Failure (AHF) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Acute Heart Failure (AHF) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Acute Heart Failure (AHF) Therapeutics by Type (2019-2025)
Table Global Consumption (K Pcs) of Acute Heart Failure (AHF) Therapeutics by Application (2019-2025)
Table Acute Heart Failure (AHF) Therapeutics Distributors List
Table Acute Heart Failure (AHF) Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bayer AG、Bristol-Myers Squibb Company、Cardiorentis AG、CVie Therapeutics Limited、Cytokinetics, Inc.、Merck & Co.、Novartis AG、Orion Corporation、PhaseBio Pharmaceuticals, Inc、

★調査レポート[世界の急性心不全(AHF)治療薬市場 2019年] (コード：DATA909X02947)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の急性心不全(AHF)治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の急性呼吸窮迫症候群(ARDS)治療薬市場 2019年
    DATA909X02949 / QYResearch / 2019年11月15日 / ※本調査レポートは、急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他に、用途別には、入院患者、外来患者にセグメント区分し、急性呼吸窮迫症候群(ARDS)治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要 ・急性呼吸窮迫症候群(ARDS)治療薬の製造コスト構成分析 ・急性呼吸窮迫症候群(ARDS)治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・急性呼吸窮迫症候群(ARDS)治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・急性呼吸窮迫症候群(ARDS)治療薬のセグメント分析（種類別） （メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他）...The global Acute Respiratory Distress Syndrome Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Respiratory Distress Syndrome Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Respiratory Distress Syndrome Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Acute Respiratory Distress Syndrome Therapeutics in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の骨髄異形成症候群（MDS）治療薬市場 2019年
    DATA909X11785 / QYResearch / 2019年11月20日 / ※本調査レポートは、骨髄異形成症候群（MDS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他に、用途別には、入院患者、外来患者にセグメント区分し、骨髄異形成症候群（MDS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・骨髄異形成症候群（MDS）治療薬の世界市場概要 ・骨髄異形成症候群（MDS）治療薬の製造コスト構成分析 ・骨髄異形成症候群（MDS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・骨髄異形成症候群（MDS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・骨髄異形成症候群（MDS）治療薬のセグメント分析（種類別） （アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他）...The global Myelodysplastic Syndrome (MDS) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Myelodysplastic Syndrome (MDS) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Myelodysplastic Syndrome (MDS) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Myelodysplastic Syndrome (MDS) Therapeutics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の呼吸器合胞体ウイルス（RSV）治療薬市場 2019年
    DATA909X14332 / QYResearch / 2019年11月20日 / ※本調査レポートは、呼吸器合胞体ウイルス（RSV）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、パリビズマブ、リバビリン、その他に、用途別には、病院薬局、ドラッグストア、小売薬局、その他にセグメント区分し、呼吸器合胞体ウイルス（RSV）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・呼吸器合胞体ウイルス（RSV）治療薬の世界市場概要 ・呼吸器合胞体ウイルス（RSV）治療薬の製造コスト構成分析 ・呼吸器合胞体ウイルス（RSV）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・呼吸器合胞体ウイルス（RSV）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・呼吸器合胞体ウイルス（RSV）治療薬のセグメント分析（種類別） （パリビズマブ、リバビリン、その他）...The global Respiratory Syncytial Virus (RSV) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Respiratory Syncytial Virus (RSV) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Respiratory Syncytial Virus (RSV) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Respiratory Syncytial Virus (RSV) Therapeutics in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の多発性硬化症（MS）治療薬市場 2019年
    DATA909X11757 / QYResearch / 2019年11月20日 / ※本調査レポートは、多発性硬化症（MS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、コパキソン（酢酸グラチラマー、共重合体1）、ノバントロン（ミトキサントロン）、ギレニア（フィンゴリモド、Fty720）、オーバジオ（テリフルノミド）、テクフィデラ（フマル酸ジメチル）、フィラテグラス（Sb683699、T-0047）、シポニモド（Baf312）、その他に、用途別には、RRMS、SPMS、PPMS、PRMSにセグメント区分し、多発性硬化症（MS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多発性硬化症（MS）治療薬の世界市場概要 ・多発性硬化症（MS）治療薬の製造コスト構成分析 ・多発性硬化症（MS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多発性硬化症（MS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多発性硬化症（MS）治療薬のセグメント分析（種類別） （コパキソン（酢酸グラチラマー、共重合体1）、ノバントロン（ミトキサントロン）、ギレニア（フィンゴリモド、Fty720）、オーバジオ（テリフルノミド）、テクフィデラ（フマル酸ジメチル）、フィラテグラス（Sb683699、T-0047）、シポニモド（Baf312）、その他）...The global Multiple Sclerosis (MS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Multiple Sclerosis (MS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Multiple Sclerosis (MS) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Multiple Sclerosis (MS) Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の肺動脈高血圧症（PAH）治療薬市場 2019年
    DATA909X13888 / QYResearch / 2019年11月20日 / ※本調査レポートは、肺動脈高血圧症（PAH）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エンドセリン受容体拮抗薬（ERA）、プロスタサイクリンおよびプロスタサイクリンアナログ、ホスホジエステラーゼ5（PDE-5）、可溶性グアニル酸シクラーゼ（SGC）刺激剤に、用途別には、二次性肺高血圧症（SPH）、原発性肺高血圧症（PPH）にセグメント区分し、肺動脈高血圧症（PAH）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・肺動脈高血圧症（PAH）治療薬の世界市場概要 ・肺動脈高血圧症（PAH）治療薬の製造コスト構成分析 ・肺動脈高血圧症（PAH）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・肺動脈高血圧症（PAH）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・肺動脈高血圧症（PAH）治療薬のセグメント分析（種類別） （エンドセリン受容体拮抗薬（ERA）、プロスタサイクリンおよびプロスタサイクリンアナログ、ホスホジエステラーゼ5（PDE-5）、可溶性グアニル酸シクラーゼ（SGC）刺激剤）...The global Pulmonary Arterial Hypertension (PAH) Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pulmonary Arterial Hypertension (PAH) Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pulmonary Arterial Hypertension (PAH) Medicine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pulmonary Arterial Hypertension (PAH) Medicine in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の多嚢胞性卵巣症候群（PCOS）治療薬市場 2019年
    DATA909X13285 / QYResearch / 2019年11月20日 / ※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬に、用途別には、病院、クリニックにセグメント区分し、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要 ・多嚢胞性卵巣症候群（PCOS）治療薬の製造コスト構成分析 ・多嚢胞性卵巣症候群（PCOS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多嚢胞性卵巣症候群（PCOS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（種類別） （経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬）...The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polycystic Ovary Syndrome (PCOS) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polycystic Ovary Syndrome (PCOS) Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の肝不全治療薬市場 2019年
    DATA909X10684 / QYResearch / 2019年11月20日 / ※本調査レポートは、肝不全治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、オルニチンフェニルアセテート、MTL-CEBPA、F-573、BL-1220、PP-100、その他に、用途別には、クリニック、病院、その他にセグメント区分し、肝不全治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・肝不全治療薬の世界市場概要 ・肝不全治療薬の製造コスト構成分析 ・肝不全治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・肝不全治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・肝不全治療薬のセグメント分析（種類別） （オルニチンフェニルアセテート、MTL-CEBPA、F-573、BL-1220、PP-100、その他）...The global Liver Failure Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Liver Failure Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liver Failure Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Liver Failure Therapeutics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆